BR112012024826A2 - processo para purificação de pneumocandina - Google Patents
processo para purificação de pneumocandinaInfo
- Publication number
- BR112012024826A2 BR112012024826A2 BR112012024826A BR112012024826A BR112012024826A2 BR 112012024826 A2 BR112012024826 A2 BR 112012024826A2 BR 112012024826 A BR112012024826 A BR 112012024826A BR 112012024826 A BR112012024826 A BR 112012024826A BR 112012024826 A2 BR112012024826 A2 BR 112012024826A2
- Authority
- BR
- Brazil
- Prior art keywords
- pneumocandin
- purification process
- purification
- crystallization
- purifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN00861/CHE/2010 | 2010-03-29 | ||
IN861CH2010 | 2010-03-29 | ||
PCT/IN2010/000313 WO2011121599A1 (en) | 2010-03-29 | 2010-05-17 | A process for purification of pneumocandin |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012024826A2 true BR112012024826A2 (pt) | 2016-06-07 |
BR112012024826B1 BR112012024826B1 (pt) | 2021-02-02 |
BR112012024826B8 BR112012024826B8 (pt) | 2021-05-25 |
Family
ID=44711425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012024826A BR112012024826B8 (pt) | 2010-03-29 | 2010-05-17 | processo para purificação de pneumocandina |
Country Status (6)
Country | Link |
---|---|
US (1) | US9399664B2 (pt) |
EP (1) | EP2552937B1 (pt) |
BR (1) | BR112012024826B8 (pt) |
CA (1) | CA2794688C (pt) |
WO (1) | WO2011121599A1 (pt) |
ZA (1) | ZA201207356B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104558123A (zh) * | 2014-12-01 | 2015-04-29 | 江苏汉邦科技有限公司 | 一种采用动态轴向压缩柱系统制备纽莫康定b0的方法 |
CN106162922B (zh) * | 2015-01-27 | 2021-01-26 | 中兴通讯股份有限公司 | 发现信号的处理方法及装置 |
CN107778357B (zh) * | 2016-08-27 | 2020-10-30 | 鲁南制药集团股份有限公司 | 一种纽莫康定b0的提取、纯化方法 |
CN106589073A (zh) * | 2017-01-20 | 2017-04-26 | 信泰制药(苏州)有限公司 | 提纯纽莫康定b0的方法 |
US20210355165A1 (en) * | 2018-10-25 | 2021-11-18 | Cidara Therapeutics, Inc. | Polymorph of echinocandin antifungal agent |
CN109400680A (zh) * | 2018-12-07 | 2019-03-01 | 成都雅途生物技术有限公司 | 一种卡泊芬净前体pneumocandinB0的结晶纯化方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310873A (en) * | 1990-03-12 | 1994-05-10 | Merck & Co., Inc. | Cyclohexapeptide compound |
CZ293547B6 (cs) * | 1998-04-23 | 2004-06-16 | Aventis Pharma Deutschland Gmbh | Způsob konverze peptidů třídy echinokandinů na jejich C4-homotyrosinmonodeoxyanalogy |
US6610822B2 (en) * | 2000-09-01 | 2003-08-26 | Merck & Co., Inc. | Purification process |
CA2537574A1 (en) | 2003-09-05 | 2005-03-24 | Merck & Co., Inc. | Stationary phases and a purification process using the stationary phases |
TW200826957A (en) * | 2006-10-16 | 2008-07-01 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Purification processes for echinocandin-type compounds |
WO2009142761A1 (en) | 2008-05-21 | 2009-11-26 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Caspofungin bo free of caspofungin co |
-
2010
- 2010-05-17 US US13/637,920 patent/US9399664B2/en active Active
- 2010-05-17 CA CA2794688A patent/CA2794688C/en active Active
- 2010-05-17 BR BR112012024826A patent/BR112012024826B8/pt active IP Right Grant
- 2010-05-17 WO PCT/IN2010/000313 patent/WO2011121599A1/en active Application Filing
- 2010-05-17 EP EP10848810.7A patent/EP2552937B1/en not_active Not-in-force
-
2012
- 2012-10-01 ZA ZA2012/07356A patent/ZA201207356B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011121599A1 (en) | 2011-10-06 |
EP2552937B1 (en) | 2018-01-17 |
US20130030149A1 (en) | 2013-01-31 |
BR112012024826B1 (pt) | 2021-02-02 |
BR112012024826B8 (pt) | 2021-05-25 |
US9399664B2 (en) | 2016-07-26 |
ZA201207356B (en) | 2013-06-26 |
CA2794688C (en) | 2018-07-03 |
EP2552937A1 (en) | 2013-02-06 |
EP2552937A4 (en) | 2013-11-13 |
CA2794688A1 (en) | 2011-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012024826A2 (pt) | processo para purificação de pneumocandina | |
BR112014007193A2 (pt) | derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos | |
BR112012019032A2 (pt) | "processo para purificação de etanol" | |
BR112015006874A2 (pt) | ligantes de rig-i inovadores e métodos para produzir os mesmos | |
BR112013025727A2 (pt) | processos para produzir gás de síntese quente e para reduzir o teor de alcatrão em gás de síntese contendo alcatrão e mecanismo de remoção de alcatrão | |
MX2016004406A (es) | Derivados de 1,4-ciclohexilamina y proceso para la preparacion de los mismos. | |
BR112014009866A2 (pt) | formulações de anticorpos e métodos | |
DOP2009000287A (es) | Oxazolidinonas sustituidas y su uso | |
BR112013020265A2 (pt) | formas de rifaximina e uso das mesmas | |
BR112015007243A2 (pt) | processo melhorado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4-trifluorometilpiridin-2-amina | |
BR112013026660A2 (pt) | métodos ou processos para produção de depsipeptídeos macrocíclicos e intermediários | |
IN2014MN01750A (pt) | ||
BR112015003957A2 (pt) | alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria | |
BR112013005849A2 (pt) | método para a produção de álcool por reação de guerbet | |
BR112015022859A2 (pt) | processo para fabricação de mono-hidrato trissódico gadofosveset | |
BR112015014335A2 (pt) | (6r,10r)-6,10,14-trimetilpentadecan-2-ona preparada a partir de 6,10-dimetilundec-5-en-2-ona ou 6,10-dimetilundeca-5,9-dien-2-ona | |
CL2015003659A1 (es) | Un proceso para la purificación de un gas de síntesis que contiene hidrógeno e impurezas. | |
BR112013028789A2 (pt) | processo | |
BR112014000889A2 (pt) | tratamento para hipoxia | |
BR112014027994A2 (pt) | métodos de cristalização para purificação de anticorpos monoclonais | |
BR112014002335A2 (pt) | mictório e processo para troca de sifão de mictório | |
BRPI1007233A2 (pt) | "processo para purificar 1, 2-propanodiol para remover impurezas por destilação, uso de 1, 2-propanodiol purificado, e, dispositivo para realizar o processo" | |
BR112015014423A2 (pt) | (6r,10r)-6,10,14-trimetilpentadecan-2-ona preparada a partir de 6,10,14-trimetilpentadeca-5,9,13-trien-2-ona ou 6,10,14-trimetilpentadeca-5,9-dien-2-ona | |
BR112013026868A2 (pt) | intermediário para a síntese de caspofungina e método para o seu preparo | |
BR112013023211A2 (pt) | ensaio diagnóstico de anticorpos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/05/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |